Report cover image

DNA & Gene Chip Market by Product (Consumables, Instruments), Array Type (cDNA-Based Microarray, Oligonucleotide-Based Microarray), Application, End-User - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 186 Pages
SKU # IRE18442521

Description

DNA & Gene Chip Market by Product (Consumables, Instruments), Array Type (cDNA-Based Microarray, Oligonucleotide-Based Microarray), Application, End-User - Global Forecast 2024-2030


The DNA & Gene Chip Market size was estimated at USD 8.77 billion in 2023 and expected to reach USD 9.71 billion in 2024, at a CAGR 11.34% to reach USD 18.61 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the DNA & Gene Chip Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the DNA & Gene Chip Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the DNA & Gene Chip Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Agilent Technologies, Inc., Arrayit Corporation, Biomérieux SA, Bioneer Corporation, CapitalBio Technology Co., Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Greiner Bio-One International GmbH, Illumina, Inc., Integrated Dna Technologies, LifeGen Technologies, LLC, Macrogen Inc., Merck KGaA, Microarrays Inc., Ocimum Biosolutions Ltd., Perkin Elmer, Inc., Promega Corporation, Savyon Diagnostics, Scienion AG by a Bico Company, Shanghai Biochip Co Ltd., Sophia Genetics SA, Surmodics Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Veritas Genetics, Inc..

Market Segmentation & Coverage

This research report categorizes the DNA & Gene Chip Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Consumables

Instruments
Array Type
cDNA-Based Microarray

Oligonucleotide-Based Microarray
Application
Diagnostics

Drug Discovery & Development

Genomics

Personalized Medicine
End-User
Academic & Research Institutes

Hospitals & Clinical Laboratories

Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the DNA & Gene Chip Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the DNA & Gene Chip Market?
3. What are the technology trends and regulatory frameworks in the DNA & Gene Chip Market?
4. What is the market share of the leading vendors in the DNA & Gene Chip Market?
5. Which modes and strategic moves are suitable for entering the DNA & Gene Chip Market?PDF E-mail From Publisher (2-5)Users License

Table of Contents

186 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. DNA & Gene Chip Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing need of DNA & gene chip for genetic analysis and diagnostics
5.1.1.2. Surging adoption of personalized medicines for cancer treatments
5.1.1.3. Increase in the demand for early cancer detection and cancer diagnosis
5.1.2. Restraints
5.1.2.1. Lack of skilled and experienced subject experts
5.1.3. Opportunities
5.1.3.1. Emerging miniaturization of DNA & gene chip
5.1.3.2. Strategic government fundings and initiatives for DNA & gene chip
5.1.4. Challenges
5.1.4.1. Concern associated with gene expression regulation and availability of alternative technologies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. DNA & Gene Chip Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Instruments
7. DNA & Gene Chip Market, by Array Type
7.1. Introduction
7.2. cDNA-Based Microarray
7.3. Oligonucleotide-Based Microarray
8. DNA & Gene Chip Market, by Application
8.1. Introduction
8.2. Diagnostics
8.3. Drug Discovery & Development
8.4. Genomics
8.5. Personalized Medicine
9. DNA & Gene Chip Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals & Clinical Laboratories
9.4. Pharmaceutical & Biotechnology Companies
10. Americas DNA & Gene Chip Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific DNA & Gene Chip Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa DNA & Gene Chip Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 23andMe, Inc.
14.1.2. Agilent Technologies, Inc.
14.1.3. Arrayit Corporation
14.1.4. Biomérieux SA
14.1.5. Bioneer Corporation
14.1.6. CapitalBio Technology Co., Ltd.
14.1.7. Eurofins Scientific SE
14.1.8. F. Hoffmann-La Roche AG
14.1.9. Greiner Bio-One International GmbH
14.1.10. Illumina, Inc.
14.1.11. Integrated Dna Technologies
14.1.12. LifeGen Technologies, LLC
14.1.13. Macrogen Inc.
14.1.14. Merck KGaA
14.1.15. Microarrays Inc.
14.1.16. Ocimum Biosolutions Ltd.
14.1.17. Perkin Elmer, Inc.
14.1.18. Promega Corporation
14.1.19. Savyon Diagnostics
14.1.20. Scienion AG by a Bico Company
14.1.21. Shanghai Biochip Co Ltd.
14.1.22. Sophia Genetics SA
14.1.23. Surmodics Inc.
14.1.24. Sysmex Corporation
14.1.25. Thermo Fisher Scientific Inc.
14.1.26. Twist Bioscience Corporation
14.1.27. Veritas Genetics, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. DNA & GENE CHIP MARKET RESEARCH PROCESS
FIGURE 2. DNA & GENE CHIP MARKET SIZE, 2023 VS 2030
FIGURE 3. DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DNA & GENE CHIP MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DNA & GENE CHIP MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DNA & GENE CHIP MARKET DYNAMICS
FIGURE 7. DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2023 VS 2030 (%)
FIGURE 10. DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. DNA & GENE CHIP MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. DNA & GENE CHIP MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us